Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001613 · ClinicalTrials.gov registry record

Cataract Surgery to Obtain Human Lens Material for the Study of Nuclear Cataracts

A clinical trial of Cataract, sponsored by National Eye Institute (NEI).

Completed
Registry status
96
Enrollment target
1
Study location

NCT00001613: Completed study of Cataract, sponsored by National Eye Institute (NEI).

NCT00001613 is a study of Cataract that has completed, run by National Eye Institute (NEI). The registered enrollment target is 96 participants, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001613, a study of Cataract, has completed, sponsored by National Eye Institute (NEI).

COMPLETED
Registry status
96 participants
Enrollment target
1
Study location

Study Summary

Cataract, in which the lens of the eye is opacified, is the major cause of blindness. This study will examine protein material of the lens called crystallins to try to determine what causes nuclear cataracts, a type of cataract that forms in the central lens nucleus. Men and women age 45 years or older with a cataract may be eligible for this study. Candidates will be screened to determine what type of cataract they have and will undergo a complete eye examination, including a vision test, eye pressure test, and examination of the lens and retina. Patients selected for study will have a complete physical and eye examination, including photography of various parts of the eye, and ultrasound measurements of the eye. They will then have cataract surgery, either with or without intraocular lens implantation, and will have follow-up examinations 1 week, 3 weeks, 5 weeks and 8 weeks after surgery. Tissue from the lenses removed during surgery will be given to NEI scientists for research on the causes of age-related nuclear cataracts.

Conditions Studied

Study Locations (1)

Maryland

  • National Eye Institute (NEI) - Bethesda

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 1997-05
Est. Completion 2002-05
National Eye Institute (NEI)

221 total trials

What the finished NCT00001613 record still lists

NCT00001613 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (58% lower).

The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 0 interventions.

NCT00001613 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00001613 about?

NCT00001613 is a clinical study titled "Cataract Surgery to Obtain Human Lens Material for the Study of Nuclear Cataracts". Cataract, in which the lens of the eye is opacified, is the major cause of blindness. This study will examine protein material of the lens called crystallins to try to determine what causes nuclear cataracts, a type of cataract that forms in the central lens nucleus. Men and women age 45 years or o...

What is the current status of trial NCT00001613?

This trial is currently completed. The enrollment target is 96 participants. The study started on 1997-05. Estimated completion is 2002-05.

What conditions does trial NCT00001613 study?

This clinical trial studies the following conditions: Cataract.

Who is sponsoring clinical trial NCT00001613?

This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00001613 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00001613's enrollment target sits among peer trials

96 39th of 83 higher than 44 of 83 other Cataract trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03401762 · 96 participants · NA

    Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke

  • NCT03471260 · 96 participants · Phase 1

    Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

  • NCT03549559 · 96 participants · NA

    Imaging Histone Deacetylase in the Heart

  • NCT03841058 · 96 participants · Phase 2

    Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00001613, the US trial registry maintained by the National Library of Medicine. NCT00001613 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.